Sivik Global Healthcare LLC Decreases Stock Position in Smith & Nephew plc (NYSE:SNN)

Sivik Global Healthcare LLC lowered its stake in shares of Smith & Nephew plc (NYSE:SNN - Free Report) by 10.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 125,000 shares of the medical equipment provider's stock after selling 15,000 shares during the period. Smith & Nephew accounts for about 1.6% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 27th biggest holding. Sivik Global Healthcare LLC's holdings in Smith & Nephew were worth $3,073,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. River Road Asset Management LLC acquired a new stake in shares of Smith & Nephew during the third quarter worth $38,588,000. Dimensional Fund Advisors LP raised its stake in Smith & Nephew by 58.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider's stock worth $12,995,000 after acquiring an additional 193,046 shares during the last quarter. Point72 DIFC Ltd acquired a new stake in Smith & Nephew during the 3rd quarter worth about $7,200,000. State Street Corp grew its stake in Smith & Nephew by 1.3% during the 3rd quarter. State Street Corp now owns 143,846 shares of the medical equipment provider's stock valued at $4,479,000 after purchasing an additional 1,889 shares during the last quarter. Finally, Raymond James & Associates increased its holdings in shares of Smith & Nephew by 172.1% in the third quarter. Raymond James & Associates now owns 128,854 shares of the medical equipment provider's stock valued at $4,013,000 after purchasing an additional 81,500 shares during the period. Institutional investors own 25.64% of the company's stock.

Analyst Ratings Changes

SNN has been the subject of several recent research reports. StockNews.com cut shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a report on Tuesday, November 12th. Berenberg Bank lowered Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Wednesday, November 6th. Finally, Deutsche Bank Aktiengesellschaft cut Smith & Nephew from a "buy" rating to a "hold" rating in a report on Friday, November 1st.

Smith & Nephew Trading Down 0.0 %

Shares of Smith & Nephew stock traded down $0.00 during trading hours on Monday, reaching $25.38. The stock had a trading volume of 260,092 shares, compared to its average volume of 829,148. Smith & Nephew plc has a twelve month low of $23.65 and a twelve month high of $31.72. The company has a current ratio of 2.51, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63. The stock's 50 day moving average is $25.05 and its 200 day moving average is $27.64.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.